BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 27106803)

  • 1. AMP-activated protein kinase α1-sensitive activation of AP-1 in cardiomyocytes.
    Voelkl J; Alesutan I; Primessnig U; Feger M; Mia S; Jungmann A; Castor T; Viereck R; Stöckigt F; Borst O; Gawaz M; Schrickel JW; Metzler B; Katus HA; Müller OJ; Pieske B; Heinzel FR; Lang F
    J Mol Cell Cardiol; 2016 Aug; 97():36-43. PubMed ID: 27106803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-activated protein kinase α1 regulates cardiac gap junction protein connexin 43 and electrical remodeling following pressure overload.
    Alesutan I; Voelkl J; Stöckigt F; Mia S; Feger M; Primessnig U; Sopjani M; Munoz C; Borst O; Gawaz M; Pieske B; Metzler B; Heinzel F; Schrickel JW; Lang F
    Cell Physiol Biochem; 2015; 35(1):406-18. PubMed ID: 25591781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of AMP-activated protein kinase α1 in angiotensin-II-induced renal Tgfß-activated kinase 1 activation.
    Mia S; Castor T; Musculus K; Voelkl J; Alesutan I; Lang F
    Biochem Biophys Res Commun; 2016 Aug; 476(4):267-272. PubMed ID: 27230958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of AMP-Activated Protein Kinase α1 Deficiency on Tissue Injury following Unilateral Ureteral Obstruction.
    Mia S; Federico G; Feger M; Pakladok T; Meissner A; Voelkl J; Groene HJ; Alesutan I; Lang F
    PLoS One; 2015; 10(8):e0135235. PubMed ID: 26285014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.
    Noppe G; Dufeys C; Buchlin P; Marquet N; Castanares-Zapatero D; Balteau M; Hermida N; Bouzin C; Esfahani H; Viollet B; Bertrand L; Balligand JL; Vanoverschelde JL; Beauloye C; Horman S
    J Mol Cell Cardiol; 2014 Sep; 74():32-43. PubMed ID: 24805196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin promotes autophagy in ischemia/reperfusion myocardium via cytoplasmic AMPKα1 and nuclear AMPKα2 pathways.
    Wang Y; Yang Z; Zheng G; Yu L; Yin Y; Mu N; Ma H
    Life Sci; 2019 May; 225():64-71. PubMed ID: 30953640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMP-Activated Protein Kinase α1 in Macrophages Promotes Collateral Remodeling and Arteriogenesis in Mice In Vivo.
    Zhu H; Zhang M; Liu Z; Xing J; Moriasi C; Dai X; Zou MH
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1868-78. PubMed ID: 27444205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JunD attenuates phenylephrine-mediated cardiomyocyte hypertrophy by negatively regulating AP-1 transcriptional activity.
    Hilfiker-Kleiner D; Hilfiker A; Castellazzi M; Wollert KC; Trautwein C; Schunkert H; Drexler H
    Cardiovasc Res; 2006 Jul; 71(1):108-17. PubMed ID: 16690042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the atypical protein kinase Czeta in regulation of 5'-AMP-activated protein kinase in cardiac and skeletal muscle.
    Ussher JR; Jaswal JS; Wagg CS; Armstrong HE; Lopaschuk DG; Keung W; Lopaschuk GD
    Am J Physiol Endocrinol Metab; 2009 Aug; 297(2):E349-57. PubMed ID: 19625676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protein kinase C phosphorylates AMP-activated protein kinase α1 Ser487.
    Heathcote HR; Mancini SJ; Strembitska A; Jamal K; Reihill JA; Palmer TM; Gould GW; Salt IP
    Biochem J; 2016 Dec; 473(24):4681-4697. PubMed ID: 27784766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deficiency of LKB1 in heart prevents ischemia-mediated activation of AMPKalpha2 but not AMPKalpha1.
    Sakamoto K; Zarrinpashneh E; Budas GR; Pouleur AC; Dutta A; Prescott AR; Vanoverschelde JL; Ashworth A; Jovanović A; Alessi DR; Bertrand L
    Am J Physiol Endocrinol Metab; 2006 May; 290(5):E780-8. PubMed ID: 16332922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crucial role for LKB1 to AMPKalpha2 axis in the regulation of CD36-mediated long-chain fatty acid uptake into cardiomyocytes.
    Habets DD; Coumans WA; El Hasnaoui M; Zarrinpashneh E; Bertrand L; Viollet B; Kiens B; Jensen TE; Richter EA; Bonen A; Glatz JF; Luiken JJ
    Biochim Biophys Acta; 2009 Mar; 1791(3):212-9. PubMed ID: 19159696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. beta-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes.
    Mani SK; Egan EA; Addy BK; Grimm M; Kasiganesan H; Thiyagarajan T; Renaud L; Brown JH; Kern CB; Menick DR
    J Mol Cell Cardiol; 2010 Feb; 48(2):342-51. PubMed ID: 19945464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
    Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
    Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AMP activated protein kinase-alpha2 deficiency exacerbates pressure-overload-induced left ventricular hypertrophy and dysfunction in mice.
    Zhang P; Hu X; Xu X; Fassett J; Zhu G; Viollet B; Xu W; Wiczer B; Bernlohr DA; Bache RJ; Chen Y
    Hypertension; 2008 Nov; 52(5):918-24. PubMed ID: 18838626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMPKα2 Protects Against the Development of Heart Failure by Enhancing Mitophagy via PINK1 Phosphorylation.
    Wang B; Nie J; Wu L; Hu Y; Wen Z; Dong L; Zou MH; Chen C; Wang DW
    Circ Res; 2018 Mar; 122(5):712-729. PubMed ID: 29284690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of AMP-activated protein kinase or protein kinase D prevents lipid-induced insulin resistance in cardiomyocytes.
    Steinbusch LK; Dirkx E; Hoebers NT; Roelants V; Foretz M; Viollet B; Diamant M; van Eys G; Ouwens DM; Bertrand L; Glatz JF; Luiken JJ
    J Mol Cell Cardiol; 2013 Feb; 55():165-73. PubMed ID: 23159540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AMP activated protein kinase-α2 regulates expression of estrogen-related receptor-α, a metabolic transcription factor related to heart failure development.
    Hu X; Xu X; Lu Z; Zhang P; Fassett J; Zhang Y; Xin Y; Hall JL; Viollet B; Bache RJ; Huang Y; Chen Y
    Hypertension; 2011 Oct; 58(4):696-703. PubMed ID: 21825219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2.
    Xu X; Lu Z; Fassett J; Zhang P; Hu X; Liu X; Kwak D; Li J; Zhu G; Tao Y; Hou M; Wang H; Guo H; Viollet B; McFalls EO; Bache RJ; Chen Y
    Hypertension; 2014 Apr; 63(4):723-8. PubMed ID: 24420540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between p38 mitogen-activated protein kinase and AMP-activated protein kinase during myocardial ischemia.
    Jacquet S; Zarrinpashneh E; Chavey A; Ginion A; Leclerc I; Viollet B; Rutter GA; Bertrand L; Marber MS
    Cardiovasc Res; 2007 Dec; 76(3):465-72. PubMed ID: 17765884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.